DETÉNGASE Y LEA ESTA ACTUALIZACIÓN IMPORTANTE DEL CORONAVIRUS (COVID-19). >> HAGA CLIC AQUÍ

This page was last updated on 8/3/2020 at 3:48 PM.

Lehigh Valley Health Network (LVHN) remains vigilant as the impact of coronavirus (COVID-19) evolves, and we are committed to being your partner in health in these unprecedented times. As a leader in infection control and prevention, LVHN is taking extraordinary steps to deliver the smart, comprehensive care you need through new ways to screen, assess, test and keep you safe.

COVID-19 Screening and Testing

COVID-19 pre-screenings

If you think you have COVID-19 or may have been exposed to someone who does, stay home. We are providing COVID-19 screenings online and by phone. You must be in the state of Pennsylvania to receive screening due to medical licensing regulations:

We want to screen you via these technologies so that you remain in your own home and only need to leave if testing is needed. This screening helps reduce the spread of COVID-19.

During the screening, our medical professionals will determine if you have COVID-19 symptoms and if you should receive testing. If needed, you will be directed to an LVHN COVID-19 Assess and Test location. The COVID-19 test detects active disease and cannot determine if you have been exposed.

If you have a medical order to receive a COVID-19 test in preparation for an upcoming procedure, and you do not have any symptoms of illness, read our pre-procedure COVID-19 testing guidance.

COVID-19 Assess and Test Locations

LVHN has opened Assess and Test locations throughout the region. They have been established to minimize our community’s exposure to COVID-19. 

 

View COVID-19 Assess and Test locations

 

Waiting protocol to protect you and others

To further reduce risk of exposure to coronavirus, we are asking patients to wait in their car instead of in the waiting room at our Assess and Test locations.

When you arrive at the Assess and Test office, go inside and check in with the registration desk. You will be asked to provide your mobile phone number. Then you can return to your car and wait until the Assess and Test office calls your mobile phone, letting you know you can be seen.

By doing this, you will reduce your risk of exposure to coronavirus in a busy waiting area, as well as potentially protect others if you do happen to have coronavirus or another infection. If you need care for another condition, you can continue to visit any open ExpressCARE location or LVPG practice.   

 

View ExpressCARE locations

 

Your COVID-19 test results
Lehigh Valley Health Network makes it convenient to view your test results, so you can focus on feeling better. After your COVID-19 test, there’s no need to wait for a provider to call you. You can view your test results and quarantine instructions as soon as they are available on the MyLVHN patient portal. If you receive positive test results, an LVHN colleague will reach out to you with guidance. Should you have questions about your results, please call 484-273-4368.

MyLVHN can be accessed from a computer or through the MyLVHN mobile app (available for Apple or Android devices). It allows you to schedule appointments, pay bills and review your medical information all in one place.

 

Learn More

 

Have an upcoming procedure?
Learn about pre-procedure COVID-19 testing.

 

Read more

Treatment and Clinical Trials

The virus impacts each person differently and the effectiveness of treatment options also differs from person to person. Rest assured, you or your loved ones will receive the treatment option that may work best for you. At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research, including COVID-19 clinical trials.

Donation of convalescent plasma for the treatment of other patients with COVID-19

Have you recovered from COVID-19? If so, you may be able to help others who are critically ill from the COVID-19 infection by donating your plasma.

When a person contracts a virus like COVID-19, their immune system creates antibodies to fight the virus. Those who have completely recovered from COVID-19 may have immune-boosting antibodies in their plasma—called “convalescent plasma”—that could be used to treat critically ill COVID-19 patients. This provides a boost to the immune system of the sick patient and may help speed the recovery process.

Miller-Keystone Blood Center is strongly encouraging plasma donations from recovered COVID-19 patients. Plasma (the liquid part of our blood) cannot be manufactured by a pharmaceutical company. Therefore, we are dependent upon donations from recovered patients to ensure that we have a continued supply of this investigational therapy.

A recovered COVID-19 patient can donate plasma 28 days after their symptoms have resolved or 14 days if they receive a negative COVID-19 test. All patients interested in donations will have the same screening performed on all blood product donors.

To become a convalescent plasma donor, contact the MyLVHN Nurse Line at 888-402-LVHN (5846).

To learn more, read frequently asked questions and visit Miller-Keystone Blood Center at GiveaPint.org.

Selinexor Clinical Trial

LVHN is among the first participants in an international clinical trial to test the effectiveness of the drug selinexor to treat COVID-19.

The placebo-controlled study looks at selinexor, marketed under the brand name XPOVIO, as a potential antiviral and anti-inflammatory treatment for COVID-19.

Selinexor, currently approved at higher doses by the Food and Drug Administration (FDA) as a treatment for patients with relapsed or refractory multiple myeloma, is what’s known as a selective inhibitor of nuclear transport, or SINE, in cells. It’s been shown that COVID-19’s ability to replicate is impaired when nuclear transport is blocked. Animal models suggest some significant reduction in viral replication.

Marcelo, Gareca, MD, Infectious Disease Specialist, the principal investigator of the study at LVHN, says the research will assess the effectiveness and safety of 20mg of selinexor given orally to patients in the hospital three times a week for two weeks. Patients tolerating therapy well and experiencing clinical benefit may be eligible to have the treatment extended to four weeks if needed.

The global study is expected to enroll approximately 230 patients at clinical sites in the US, Europe, and Israel, including LVHN.

Remdesivir

LVHN hospitals are using the antiviral medication, remdesivir, to treat patients in the hospital with COVID-19. Lehigh Valley Hospital–Cedar Crest, Lehigh Valley Hospital–Muhlenberg and Lehigh Valley Hospital–Hazleton received the drug through the Pennsylvania Department of Health as part of a federal distribution of 1,200 doses.

Remdesivir is given to a patient through an IV once per day for at least five days. According to the Food and Drug Administration (FDA), remdesivir may help decrease the amount of coronavirus in a person’s body, which may help them get better faster.

According to Timothy Friel, MD, Chair, LVHN’s Department of Medicine, it is the first antiviral medication that has been associated with a faster recovery time in infected COVID-19 patients enrolled in an international randomized, placebo-controlled clinical trial.

With COVID-19, our commitment to safety is more evident than ever. We are taking every possible precaution in every location where we see patients.

E-Visit Screening for COVID-19

An E-Visit, through MyLVHN, is a no-appointment way to get screened for COVID-19.

Learn More

Get email updates

Receive COVID-19 email updates, access video visits and more with MyLVHN.

Sign up for MyLVHN